The future of Artificial Intelligence for the BioTech Big Data landscape

Recent Industry 4.0 advancements are making available massive amounts of data for the development of innovative BioTech solutions. However, several challenges need to be overcome to correctly use data and novel, non-pharma technologies to greatly speed up discovery, optimization and market delivery...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Current opinion in biotechnology Ročník 76; s. 102714
Hlavní autoři: Artico, Fausto, Edge III, Arthur L, Langham, Kyle
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Elsevier Ltd 01.08.2022
Témata:
artificial intelligence
biotechnology
computer software
industry
information technology
infrastructure
landscapes
markets
ADT
EDA
APIs
AI
Industry 4.0
IaC
MI
IoT
ML
Data Science
DevOps
Hyper-Automation
Data Engineering
Infrastructure as Code
Artificial Intelligence
Big Data, BioTech
Agile
Machine Learning
Deep Learning
Data Mapping
ISSN:0958-1669, 1879-0429, 1879-0429
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Recent Industry 4.0 advancements are making available massive amounts of data for the development of innovative BioTech solutions. However, several challenges need to be overcome to correctly use data and novel, non-pharma technologies to greatly speed up discovery, optimization and market delivery of products, and services. In this review, we bring your attention to the important aspects of Big Data and Artificial Intelligence (AI) that have an impact on the future of the field and briefly touch upon how disciplines such as Hyper-Automation, Infrastructure as Code (IaC) and DevOps — a set of practices that combines software development with Information Technology (IT) operations (Ops) — can accelerate Big Data and AI adoption in your Agile Digital Transformation journey. [Display omitted] •Important phases to execute in BioTech Big Data projects to prepare data for AI/ML work.•Brief description and advice on the two main types of data structures to use in BioTech.•Important aspects to consider when you want to use Artificial Intelligence in BioTech.•Technologies that can further accelerate value creation in BioTech with Big Data and AI.•Dynamics and benefits generated by adding Hyper-Automation, DevOps, and Agile methods.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Review-3
ISSN:0958-1669
1879-0429
1879-0429
DOI:10.1016/j.copbio.2022.102714